Clinical Resources

Zika Resources:

Providing Family Planning Care for Non-Pregnancy Women and Men of Reproductive Age in the Context of Zika: A Toolkit for Healthcare Providers by the Office of Population Affairs

This toolkit was developed to help providers of family planning services in a variety of settings educate their non-pregnant clients about the risk of Zika infection. The toolkit is based on current Centers for Disease Control and Prevention (CDC) guidance and is composed of the following components: 

  • Core information about Zika virus and its implications for women's and men's family planning needs
  • Guidance for healthcare providers on counseling non-pregnant women about family planning in the context of Zika
  • Guidance for healthcare providers on counseling men about family planning in the context of Zika
  • Links to CDC's clinical recommendations about Zika and other relevant resources
  • Job aids and client handouts
  • Outreach materials

Biting Back: Contraception and Zika Prevention Webinar

The latest guidance on Zika and the role of contraception, including Long-Acting Reversible Contraception (LARC) methods, is discussed during the ACOG LARC Program’s free, open-access webinar led by Melissa Kottke, MD, MPH, MBA. Upon completion of the presentation, participants will be able to:

  • Discuss the current understanding of Zika activity and sequelae
  • Describe strategies for Zika prevention
  • Outline the latest guidance surrounding Zika in the family planning setting, including the role LARC methods can play

ACOG Zika Webpage

This webpage is a resource summary for Zika information from ACOG, CDC, and other organizations.

ACOG Resources:

ACOG Practice Bulletin #121 (Reaffirmed 2015): Long-Acting Reversible Contraception: Implants and Intrauterine Devices

This Practice Bulletin provides recommendations for the use of IUDs and contraceptive implants, the most effective reversible contraceptives. The document provides information for appropriate candidate selection and the management of clinical issues and complications associated with LARC methods. The LARC Program has also developed an educational slide set based on clinical recommendations from this Practice Bulletin.

ACOG Committee Opinion #539 (Reaffirmed 2014): Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices

This Committee Opinion recommends the use of IUDs and the contraceptive implant as first-line contraceptive options for sexually active adolescents. The LARC Program has also developed an educational slide set based on clinical recommendations from this Committee Opinion.

ACOG Committee Opinion #542 (2012): Access to Emergency Contraception 

This Committee Opinion examines the barriers to use of emergency contraceptive methods and highlights the importance of increasing access to these methods. Age restrictions, cost, insurance coverage, and misconceptions about EC are all unnecessary barriers that continue to keep women from using this safe and effective method to prevent unwanted pregnancies in the first few days after unprotected sex, sexual assault, or contraceptive failure.

ACOG Committee Opinion #642 (2015): Increasing Access to Contraceptive Implants and Intrauterine Devices To Reduce Unintended Pregnancy

This Committee Opinion encourages the consideration of implants and IUDs for all appropriate candidates, including nulliparous women and adolescents, and recommends strategies to reduce barriers and increase access to LARC as part of the entire family of contraceptive methods.

ACOG Committee Opinion #670 (2016): Immediate Postpartum Long-Acting Reversible Contraception

This Committee Opinion encourages prenatal counseling of the most effective options for postpartum contraception: IUDs and the implant. Providers should counsel women about the convenience and effectiveness of immediate postpartum LARC, as well as the benefits of reducing unintended pregnancy and lengthening interpregnancy intervals. 

Obstetrics & Gynecology: Long-Acting Reversible Contraception: Intrauterine Devices and the Contraceptive Implant

This Clinical Expert Series article provides a review of LARC methods, including candidate selection, non-contraceptive benefits, and management of complications.

Other Resources:

Journal of Adolescent Health: April 2013 Supplement on Long Acting Reversible Contraceptives for Adolescents and Young Adults

This supplement features a broad range of current research on LARC, covering topics such as effective contraceptive counseling strategiesmyths about LARCpelvic inflammatory disease and IUD usecost as a barrier to LARC use in adolescents, and the effect of LARC on rapid repeat pregnancy in adolescents.

U.S. Selected Practice Recommendations for Contraceptive Use, 2016

The CDC released this resource offering guidance to health care providers in managing common issues around the initiation and use of specific contraceptive methods. The U.S. Selected Practice Recommendations were produced as a companion piece to the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. While the U.S. Medical Eligibility Criteria addresses who can use various contraceptive methods, the U.S. Selected Practice Recommendations offers method-specific guidance on common clinical issues, such as what clinical information is needed before method initiation and how to manage side effects. 

CDC: US Medical Eligibility Criteria for Contraceptive Use iPhone/iPad Application

This iPhone/iPad app from the CDC is based on the US Medical Eligibility Criteria for Contraceptive Use, 2016 (US MEC) and gives providers an interactive way to access more than 1,800 recommendations for the safety of contraceptive methods among women and men with certain characteristics or medical conditions.  

The ACOG Committee Opinion #505 (Reaffirmed 2014): Understanding and Using the U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 can also be a helpful aid in the understanding and use of the US MEC.

The resources listed above are for information purposes only. Referral to these sources and sites does not imply the endorsement of ACOG. Further, ACOG does not endorse any commercial products that may be advertised or available from these organizations or on these web sites. These lists are not meant to be comprehensive. The exclusion of a source or site does not reflect the quality of that source or site. Please note that sites and URLs are subject to change without notice.

The information contained in slide sets is designed to aid practitioners in making decisions about appropriate obstetric and gynecologic care. This information should not be construed as dictating an exclusive course of treatment or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to the institution or type of practice.


Mica Bumpus
Manager, LARC Program

For media inquiries about LARC, please contact:

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998